Alternative to chemotherapy under trial

Cancer Research UK has launched a clinical trial into an alternative lung cancer drug. It hopes it will help to extend the lives of extremely ill patients. The trial, which involves 664 patients across the UK, is testing a non-cytotoxic drug called Tarveca. If successful, it could be offered to patients with advanced lung cancer - a type of cancer that is very difficult to treat. Taken as a simple white pill, the drug targets a molecule called the epidermal growth factor receptor (EGFR), which has a key role in the growth and extended lifespan of cancer cells. Scientists have discovered t...